NFKB1 and gastric cancer: Aiming to understand better the contribution of KCND2 in promoting gastric cancer cell proliferation through NF‐κB activation, we knocked down KCND2 expression and treated cells with lipopolysaccharide (LPS), a commonly used activator of the NF‐κB pathway.